Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin for Palmar Hyperhidrosis
NCT01310712Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Dec 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in palmar hyperhidrosis (PH) comparing Oxybutynin with Placebo (2 arms). Primary endpoint: Improvement of Quality of life at 6 weeks. Started Dec 2010; status: completed.
02
Drugs
oxybutynin
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT01310712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310712.